Evaluation of efficacy of hi-ora mouthrinse as against 0.12% chlorhexidine in treatment of patients with chronic gingivitis: A randomized-controlled trial

Abstract

Background: The present study was planned to compare the efficacy of Hi-Ora mouthrinse as against 0.12% chlorhexidine (CHX) in treatment of patients with chronic gingivitis. Materials and Methods: The present study was designed as a randomized controlled trial including 90 patients with chronic gingivitis who were divided into three groups including Group A in which 0.12% CHX was prescribed, Group B in which patients were prescribed Hi-Ora, and Group C in which normal saline was prescribed after oral prophylaxis while the mean gingival index (GI) and plaque index (PI) scores were recorded after 1 week. Inter-group comparisons between different groups were done with the help of Independent t-test and Tukey's post hoc test while P < 0.05 was considered statistically significant. Results: In the present study, the mean GI score (postintervention) was found to be 0.71 ± 0.27 in CHX, 0.68 ± 0.17 in Hi-Ora, and 1.59 ± 0.55 in the normal saline group with the results being statistically significant (P < 0.0001). Similarly, the mean PI score in the present study was found to be 0.81 ± 0.34 in the CHX group with the corresponding values being 0.79 ± 0.28 in Hi-Ora and 1.86 ± 0.61 in the normal saline group with statistically significant results (P < 0.0001). Conclusions: The results of the present study suggested Hi-Ora to be equally efficacious as 0.12% CHX in reducing the mean GI and PI scores in patients with chronic gingivitis.